Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Chemoradiation and Trastuzumab	102
Overall Study	STARTED	Chemoradiation	101
Overall Study	Eligible	Chemoradiation and Trastuzumab	98
Overall Study	Eligible	Chemoradiation	96
Overall Study	Eligible and Started Study Treatment	Chemoradiation and Trastuzumab	95
Overall Study	Eligible and Started Study Treatment	Chemoradiation	96
Overall Study	Eligible and Had Surgery	Chemoradiation and Trastuzumab	82
Overall Study	Eligible and Had Surgery	Chemoradiation	78
Overall Study	Eligible and Consented to Quality of Life Component	Chemoradiation and Trastuzumab	88
Overall Study	Eligible and Consented to Quality of Life Component	Chemoradiation	83
Overall Study	COMPLETED	Chemoradiation and Trastuzumab	98
Overall Study	COMPLETED	Chemoradiation	96
Overall Study	NOT COMPLETED	Chemoradiation and Trastuzumab	4
Overall Study	NOT COMPLETED	Chemoradiation	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01196390/flow